Status:
COMPLETED
Immunointervention With Calcitriol in New-Onset Type 1 Diabetes
Lead Sponsor:
Institut fur Diabetesforschung, Munich, Germany
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
18-39 years
Phase:
PHASE2
Brief Summary
This is a randomized, two-arm, placebo-controlled phase-2 trial to determine whether the daily intake of 1,25-dihydroxy-vitamin D3 \[1,25(OH)2D3\], improves beta cell function in patients with recentl...
Eligibility Criteria
Inclusion
- New onset Typ 1 diabetes (\< 6 weeks insulin therapy)
- Age 18-39 years
- GADA and/or IA-2A positive
Exclusion
- Kidney disease
- Pregnancy
- Lactating
Key Trial Info
Start Date :
June 1 2001
Trial Type :
INTERVENTIONAL
End Date :
August 1 2008
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00960635
Start Date
June 1 2001
End Date
August 1 2008
Last Update
August 18 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut fuer Diabetesforschung
Munich, Germany, 80804